Treatment Trial for Psychogenic Nonepileptic Seizures
Status:
Completed
Trial end date:
2013-06-01
Target enrollment:
Participant gender:
Summary
The investigators propose that patients who receive targeted pharmacotherapy (sertraline) or
focused psychotherapy (cognitive behavioral therapy-informed psychotherapy (CBT-ip) for NES)
or combined treatment (CBT-ip + sertraline) will report fewer nonepileptic seizures (NES)
compared to patients who receive community care / treatment as usual (TAU). The purpose of
this study is to provide pilot testing and data to inform the future multicenter randomized
controlled trial based on the hypothesis.
Phase:
Phase 4
Details
Lead Sponsor:
Rhode Island Hospital
Collaborators:
American Epilepsy Society Epilepsy Foundation Stanford University University of Cincinnati